Clinical Outcomes With a New Monofocal IOL Enhanced for Intermediate Vision

NCT04904887 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-05-27

No results posted yet for this study

Summary

phacoemulsification with insertion of EYHANCE IOL to improve near and intermediate vision

Conditions

Interventions

PROCEDURE

phacoemulsification

phacoemulsification with implantation of EYEHANCE IOL

Sponsors & Collaborators

  • Dar Al Shifa Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-07-30
Completion
2021-10-30

Countries

  • Kuwait

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04904887 on ClinicalTrials.gov